Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial
- PMID: 24702835
- PMCID: PMC4181666
- DOI: 10.1016/S0140-6736(14)60157-4
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial
Abstract
Background: Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed. Our aim was to investigate whether low-dose aspirin improved livebirth rates in women with one to two previous pregnancy losses.
Methods: In this multicentre, block-randomised, double-blind, placebo-controlled trial, women aged 18-40 years who were attempting to become pregnant were recruited from four medical centres in the USA. Participants were stratified by eligibility criteria--the original stratum was restricted to women with one loss at less than 20 weeks' gestation during the previous year, whereas the expanded stratum included women with one to two previous losses, with no restrictions on gestational age or time of loss. Women were block-randomised by centre and eligibility stratum in a 1:1 ratio. Preconception-initiated daily low-dose aspirin (81 mg per day) plus folic acid was compared with placebo plus folic acid for up to six menstrual cycles; for women who conceived, study treatment continued until 36 weeks' gestation. Participants, trial staff, and investigators were masked to the assigned treatment. The primary outcome was livebirth rate, which was analysed by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00467363.
Findings: Overall, 1228 women were recruited and randomly assigned between June 15, 2007, and July 15, 2011, 1078 of whom completed the trial and were included in the analysis (535 in the low-dose aspirin group and 543 in the placebo group). 309 (58%) women in the low-dose aspirin group had livebirths, compared with 286 (53%) in the placebo group (p=0·0984; absolute difference in livebirth rate 5·09% [95% CI -0·84 to 11·02]). Pregnancy loss occurred in 68 (13%) women in the low-dose aspirin group, compared with 65 (12%) women in the placebo group (p=0·7812). In the original stratum, 151 (62%) of 242 women in the low-dose aspirin group had livebirths, compared with 133 (53%) of 250 in the placebo group (p=0·0446; absolute difference in livebirth rate 9·20% [0·51 to 17·89]). In the expanded stratum, 158 (54%) of 293 women in the low-dose aspirin group and 153 (52%) of 293 in the placebo group had livebirths (p=0·7406; absolute difference in livebirth rate 1·71% [-6·37 to 9·79]). Major adverse events were similar between treatment groups. Low-dose aspirin was associated with increased vaginal bleeding, but this adverse event was not associated with pregnancy loss.
Interpretation: Preconception-initiated low-dose aspirin was not significantly associated with livebirth or pregnancy loss in women with one to two previous losses. However, higher livebirth rates were seen in women with a single documented loss at less than 20 weeks' gestation during the previous year. Low-dose aspirin is not recommended for the prevention of pregnancy loss.
Funding: Eunice Kennedy Shriver National Institute of Child Health and Human Development (US National Institutes of Health).
Copyright © 2014 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Comment in
-
Improving livebirth rates: a role for preconception aspirin?Lancet. 2014 Jul 5;384(9937):5-6. doi: 10.1016/S0140-6736(14)60112-4. Epub 2014 Apr 2. Lancet. 2014. PMID: 24702834 No abstract available.
-
Preconception-initiated, low-dose aspirin did not increase live birth after 1 or 2 pregnancy losses.Ann Intern Med. 2014 Sep 16;161(6):JC13. doi: 10.7326/0003-4819-161-6-201409160-02013. Ann Intern Med. 2014. PMID: 25222413 No abstract available.
-
Antithrombotic therapy for pregnancy complications: let's not throw the baby out with the bath water.Evid Based Med. 2015 Feb;20(1):10. doi: 10.1136/ebmed-2014-110078. Epub 2014 Sep 15. Evid Based Med. 2015. PMID: 25225334 No abstract available.
Similar articles
-
Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.Hum Reprod. 2016 Mar;31(3):657-65. doi: 10.1093/humrep/dev329. Epub 2016 Jan 11. Hum Reprod. 2016. PMID: 26759138 Free PMC article. Clinical Trial.
-
A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics.Paediatr Perinat Epidemiol. 2013 Nov;27(6):598-609. doi: 10.1111/ppe.12088. Epub 2013 Oct 11. Paediatr Perinat Epidemiol. 2013. PMID: 24118062 Free PMC article. Clinical Trial.
-
Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.J Clin Endocrinol Metab. 2017 May 1;102(5):1495-1504. doi: 10.1210/jc.2016-2917. J Clin Endocrinol Metab. 2017. PMID: 28323989 Free PMC article. Clinical Trial.
-
Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.Medicine (Baltimore). 2017 Nov;96(46):e8735. doi: 10.1097/MD.0000000000008735. Medicine (Baltimore). 2017. PMID: 29145319 Free PMC article. Review.
-
Managing pre-existing diabetes prior to and during pregnancy.Aust Prescr. 2024 Feb;47(1):2-6. doi: 10.18773/austprescr.2024.002. Aust Prescr. 2024. PMID: 38444894 Free PMC article. Review.
Cited by
-
Preconception Phthalate Exposure and Women's Reproductive Health: Pregnancy, Pregnancy Loss, and Underlying Mechanisms.Environ Health Perspect. 2023 Dec;131(12):127013. doi: 10.1289/EHP12287. Epub 2023 Dec 13. Environ Health Perspect. 2023. PMID: 38088888 Free PMC article.
-
Examination of newborn DNA methylation among women with polycystic ovary syndrome/hirsutism.Epigenetics. 2023 Dec;18(1):2282319. doi: 10.1080/15592294.2023.2282319. Epub 2023 Nov 22. Epigenetics. 2023. PMID: 37992405 Free PMC article.
-
The Role of Acetylsalicylic Acid in the Prevention of Pre-Eclampsia, Fetal Growth Restriction, and Preterm Birth.Dtsch Arztebl Int. 2023 Sep 15;120(37):617-626. doi: 10.3238/arztebl.m2023.0133. Dtsch Arztebl Int. 2023. PMID: 37378599 Free PMC article. Review.
-
The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss.Epidemiology. 2023 Sep 1;34(5):759-766. doi: 10.1097/EDE.0000000000001631. Epub 2023 Jul 31. Epidemiology. 2023. PMID: 37255247 Free PMC article.
-
The Effect of Short-Term Aspirin Administration during Programmed Frozen-Thawed Embryo Transfer on Pregnancy Outcomes and Complications.J Clin Med. 2023 Jan 30;12(3):1064. doi: 10.3390/jcm12031064. J Clin Med. 2023. PMID: 36769712 Free PMC article.
References
-
- Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796–1799. - PubMed
-
- Risch HA, Weiss NS, Clarke EA, Miller AB. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol. 1988;128:420–430. - PubMed
-
- Silver RM, Branch DW. Sporadic and recurrent pregnancy loss. In: Reece EA, Hobbins JC, editors. Medicine of the fetus and mother. 2nd Edition ed. Philadelphia: J.B. Lippincott Company; 1999. pp. 195–216.
-
- Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255–258. - PubMed
-
- Di NM, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 2005;(2):CD004734. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical